Cartesio D’Agostini
- Immunology top 10%
- Epidemiology
- Molecular Biology
- Infectious Diseases top 10%
- Oncology
- Co-authors
- Enrico GaraciAnna Teresa PalamaraCartesio FavalliMaria Rosa CirioloGiuseppe RotilioSandro GrelliAntonio MastinoFrancesca Pica
- Topics
- COVID-19 Clinical Research Studies (5 papers)HIV Research and Treatment (4 papers)Antibiotic Resistance in Bacteria (4 papers)
- Journals
- PLoS ONEInternational Journal of Molecular SciencesAnnals of the New York Academy of Sciences
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Cartesio D’Agostini
39 papers receiving 798 citations
Peers
Comparison fields: 5 of 104
- Immunology 238
- Epidemiology 201
- Molecular Biology 187
- Infectious Diseases 178
- Oncology 84
Countries citing papers authored by Cartesio D’Agostini
This map shows the geographic impact of Cartesio D’Agostini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cartesio D’Agostini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cartesio D’Agostini more than expected).
Fields of papers citing papers by Cartesio D’Agostini
This network shows the impact of papers produced by Cartesio D’Agostini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cartesio D’Agostini. The network helps show where Cartesio D’Agostini may publish in the future.
Co-authorship network of co-authors of Cartesio D’Agostini
This figure shows the co-authorship network connecting the top 25 collaborators of Cartesio D’Agostini. A scholar is included among the top collaborators of Cartesio D’Agostini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cartesio D’Agostini. Cartesio D’Agostini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 7 | |
| 5 | 3 | |
| 6 | 2 | |
| 7 | 8 | |
| 8 | 2 | |
| 9 | 1 | |
| 10 | 4 | |
| 11 | 25 | |
| 12 | 14 | |
| 13 | 29 | |
| 14 | 26 | |
| 15 | 2 | |
| 16 | 77 | |
| 17 | 61 | |
| 18 | 5 | |
| 19 | 35 | |
| 20 | 29 |
About Cartesio D’Agostini
Cartesio D’Agostini is a scholar working on Applied Microbiology and Biotechnology, Microbiology and Virology, having authored 43 papers that have together received 826 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), HIV Research and Treatment (4 papers) and Antibiotic Resistance in Bacteria (4 papers). The work is most often cited by research in Virology (66 citations), Immunology (238 citations) and Infectious Diseases (178 citations). Cartesio D’Agostini has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Enrico Garaci, Anna Teresa Palamara, Cartesio Favalli, Maria Rosa Ciriolo, Giuseppe Rotilio, Sandro Grelli, Antonio Mastino, Francesca Pica, Carlo Federico Perno and Luciana Dini. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.